Dow Jones Newswires: Teladoc Health shares rise 5% following improved outlook

Teladoc Health shares rose 5%, to $23.94, in aftermarket trading Tuesday following its latest quarterly results and current outlook.

Previous post Dow Jones Newswires: Crane lifts 2023 sales, adjusted operating margin forecasts
Next post Dow Jones Newswires: Tootsie Roll sees ‘significantly higher’ ingredient costs into 2024